Prognostic O
impact O
of O
pathological O
complete O
remission O
after O
preoperative O
irradiation O
in O
patients O
with O
locally O
advanced O
head O
and O
neck O
squamous O
cell O
carcinoma O
: O
re O
- O
analysis O
of O
a O
phase B-STYPE
3 I-STYPE
clinical I-STYPE
study I-STYPE
Prognostic O
impact O
of O
pathological O
complete O
remission O
after O
preoperative O
irradiation O
in O
patients O
with O
locally O
advanced O
head O
and O
neck O
squamous O
cell O
carcinoma O
: O
re O
- O
analysis O
of O
a O
phase B-STYPE
3 I-STYPE
clinical I-STYPE
study I-STYPE
05 O
Mar O
, O
2014 O
05 O
Mar O
, O
2014 O
KaiWang B-AUTH

Department O
of O
Radiation O
Oncology O
, O
National O
Cancer O
Center O
/ O
Cancer O
Hospital O
, O
Chinese O
Academy O
of O
Medical O
Sciences O
and O
Peking O
Union O
Medical O
College O
Beijing O
China O
JunlinYi B-AUTH
yijunlin1969@163.com O

Department O
of O
Radiation O
Oncology O
, O
National O
Cancer O
Center O
/ O
Cancer O
Hospital O
, O
Chinese O
Academy O
of O
Medical O
Sciences O
and O
Peking O
Union O
Medical O
College O
Beijing O
China O
XiaodongHuang O

Department O
of O
Radiation O
Oncology O
, O
National O
Cancer O
Center O
/ O
Cancer O
Hospital O
, O
Chinese O
Academy O
of O
Medical O
Sciences O
and O
Peking O
Union O
Medical O
College O
Beijing O
China O
YuanQu B-AUTH

Department O
of O
Radiation O
Oncology O
, O
National O
Cancer O
Center O
/ O
Cancer O
Hospital O
, O
Chinese O
Academy O
of O
Medical O
Sciences O
and O
Peking O
Union O
Medical O
College O
Beijing O
China O
JingweiLuo B-AUTH

Department O
of O
Radiation O
Oncology O
, O
National O
Cancer O
Center O
/ O
Cancer O
Hospital O
, O
Chinese O
Academy O
of O
Medical O
Sciences O
and O
Peking O
Union O
Medical O
College O
Beijing O
China O
JianpingXiao B-AUTH
ShipingZhang B-AUTH

Department O
of O
Radiation O
Oncology O
, O
National O
Cancer O
Center O
/ O
Cancer O
Hospital O
, O
Chinese O
Academy O
of O
Medical O
Sciences O
and O
Peking O
Union O
Medical O
College O
Beijing O
China O
YuanTang B-AUTH

Department O
of O
Radiation O
Oncology O
, O
National O
Cancer O
Center O
/ O
Cancer O
Hospital O
, O
Chinese O
Academy O
of O
Medical O
Sciences O
and O
Peking O
Union O
Medical O
College O
Beijing O
China O
WeixinLiu B-AUTH

Department O
of O
Radiation O
Oncology O
, O
National O
Cancer O
Center O
/ O
Cancer O
Hospital O
, O
Chinese O
Academy O
of O
Medical O
Sciences O
and O
Peking O
Union O
Medical O
College O
Beijing O
China O
LiGao B-AUTH

Department O
of O
Radiation O
Oncology O
, O
National O
Cancer O
Center O
/ O
Cancer O
Hospital O
, O
Chinese O
Academy O
of O
Medical O
Sciences O
and O
Peking O
Union O
Medical O
College O
Beijing O
China O
ZhengangXu B-AUTH

Prognostic O
impact O
of O
pathological O
complete O
remission O
after O
preoperative O
irradiation O
in O
patients O
with O
locally O
advanced O
head O
and O
neck O
squamous O
cell O
carcinoma O
: O
re O
- O
analysis O
of O
a O
phase B-STYPE
3 I-STYPE
clinical I-STYPE
study I-STYPE

Prognostic O
impact O
of O
pathological O
complete O
remission O
after O
preoperative O
irradiation O
in O
patients O
with O
locally O
advanced O
head O
and O
neck O
squamous O
cell O
carcinoma O
: O
re O
- O
analysis O
of O
a O
phase B-STYPE
3 I-STYPE
clinical I-STYPE
study I-STYPE
KaiWang B-AUTH

China O
Beijing O
China O
Department O
of O
Radiation O
Oncology O
, O
National O
Cancer O
Center O
/ O
Cancer O
Hospital O
, O
Chinese O
Academy O
of O
Medical O
Sciences O
and O
Peking O
Union O
Medical O
College O
Beijing O

China O
Beijing O
China O
Prognostic O
impact O
of O
pathological O
complete O
remission O
after O
preoperative O
irradiation O
in O
patients O
with O
locally O
advanced O
head O
and O
neck O
squamous O
cell O
carcinoma O
: O
re O
- O
analysis O
of O
a O
phase B-STYPE
3 I-STYPE
clinical I-STYPE
study I-STYPE
05 O
Mar O
, O
2014 O
05 O
Mar O
, O
2014 O
05 O
Mar O
, O
2014 O
10.1186 O
/ O
s13014 O
- O
019 O
- O
1428 O
- O
4 O

Although O
surgery O
followed O
by O
radiotherapy O
and/or O
concurrent O
chemoradio O
- O
therapy O
has O
been O
the O
major O
treatment O
choice O
recommended O
by O
the O
NCCN O
guideline O
for O
treating O
locally O
advanced O
head O
and O
neck O
squamous O
cell O
carcinoma O
( O
HNSCC O
) O
for O
many O
years O
[ O
1 O
] O
, O
the O
outcome O
with O
this O
regimen O
is O
still O
limited O
by O
a O
low O
5-year O
survival O
rate O
, O
which O
remains O
< O
40 O
% O
[ O
2,3 O
] O
. O
In O
recent O
years O
, O
several O
researches O
have O
suggested O
that O
preoperative O
radiotherapy O
and O
preoperative O
concurrent O
chemoradiotherapy O
may O
improve O
the O
overall O
survival O
( O
OS O
) O
compared O
to O
surgery O
alone O
in O
patients O
with O
head O
and O
neck O
cancer O
[ O
4][5][6 O
] O
. O
The O
advantages O
of O
preoperative O
radiotherapy O
or O
preoperative O
concurrent O
chemoradiotherapy O
for O
head O
and O
neck O
cancer O
include O
down O
- O
staging O
, O
increased O
resectability O
rate O
, O
etc O
. O
Further O
evidence O
from O
several O
phase O
2 O
studies O
have O
shown O
that O
preoperative O
concurrent O
chemoradiotherapy O
provides O
excellent O
treatment O
outcomes O
by O
leading O
to O
a O
pathological O
complete O
response O
rate O
ranging O
from O
35 O
to O
61 O
% O
and O
an O
increased O
5-year O
OS O
rate O
of O
up O
to O
70 O
- O
81.5 O
% O
[ O
5][6][7][8 O
] O
. O

Several O
authors O
have O
suggested O
that O
the O
pathological O
response O
to O
preoperative O
radiotherapy O
or O
chemoradiotherapy O
is O
a O
valuable O
prognostic O
factor O
for O
local O
control O
and O
OS O
[ O
9,10 O
] O
. O
In O
one O
of O
our O
randomized B-STYPE
phase I-STYPE
3 I-STYPE
studies I-STYPE
, O
we O
evaluated O
the O
role O
of O
adding O
concurrent B-DESC
cisplatin I-DESC
to I-DESC
preoperative  B-DESC
radiotherapy I-DESC
in O
the O
treatment O
of O
locally O
advanced O
HNSCC O
[ O
11 O
] O
. O
In O
this O
study O
, O
222 O
eligible O
patients O
were O
randomly O
assigned O
to O
a O
preoperative B-DESC
radiotherapy I-DESC
group I-DESC
( O
n O
= O
118 O
) O
or O
a O
preoperative B-DESC
concurrent I-DESC
chemoradiotherapy I-DESC
group I-DESC
( O
n O
= O
104 O
) O
. O
The O
results O
revealed O
that O
preoperative B-DESC
concurrent I-DESC
chemoradiotherapy I-DESC
led O
to O
a O
significantly O
improved O
distant O
metastasis O
- O
free O
survival O
( O
DMFS O
) O
compared O
to O
preoperative B-DESC
radiotherapy I-DESC
alone I-DESC
. O
According O
to O
the O
protocol O
, O
non O
- O
responders O
( O
defined O
by O
< O
80 O
% O
reduction O
of O
the O
primary O
lesion O
after O
preoperative O
treatment O
) O
, O
subsequently O
underwent O
resection O
of O
the O
primary O
lesion O
with O
or O
without O
neck O
dissection O
depending O
on O
the O
nodal O
status O
. O
In O
total O
, O
72 O
non O
- O
responders O
( O
33.8 O
% O
) O
were O
observed O
in O
this O
phase B-STYPE
3 I-STYPE
study I-STYPE
. O

In O
the O
present O
study O
, O
we O
analyzed O
the O
relationships O
between O
pathological O
complete O
remission O
( O
pCR O
) O
and O
clinical O
outcomes O
in O
these O
72 O
non O
- O
responder O
patients O
. O

The O
details O
of O
the O
study O
design O
and O
data O
collection O
have O
been O
published O
in O
our O
previous O
study O
[ O
11 O
] O
. O
In O
brief O
, O
from O
September O
2002 O
to O
May O
2012 O
, O
a O
total O
of O
222 O
HNSCC O
patients O
were O
enrolled O
in O
this O
phase B-STYPE
3 I-STYPE
study I-STYPE
, O
among O
which O
104 O
patients O
were O
assigned O
to O
the O
preoperative B-DESC
concurrent I-DESC
chemoradiotherapy I-DESC
group I-DESC
and O
118 O
patients O
were O
assigned O
to O
the O
preoperative B-DESC
radiotherapy I-DESC
group I-DESC
. O